Genetic Effects of NDUFAF6 rs6982393 and APOE on Alzheimer’s Disease in Chinese Rural Elderly: A Cross-Sectional Population-Based Study

References

• Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–e671. doi:10.1016/S2468-2667(20)30185-7
   PubMed Web of Science ®Google Scholar
• Xu J, Wang J, Wimo A, Fratiglioni L, Qiu C. The economic burden of dementia in China, 1990–2030: implications for health policy. Bull World Health Organ. 2017;95(1):18–26. doi:10.2471/BLT.15.167726
   PubMed Web of Science ®Google Scholar
• Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483–491. doi:10.1016/j.jalz.2017.12.006
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. doi:10.1002/alz.12328
   PubMed Web of Science ®Google Scholar
• Lai X, Wen H, Li Y, Lu L, Tang C. The comparative efficacy of multiple interventions for mild cognitive impairment in Alzheimer’s disease: a Bayesian network meta-analysis. Front Aging Neurosci. 2020;12:121. doi:10.3389/fnagi.2020.00121
   PubMed Web of Science ®Google Scholar
• Nicoll JA, Savva GM, Stewart J, Matthews FE, Brayne C, Ince P. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol Appl Neurobiol. 2011;37(3):285–294. doi:10.1111/j.1365-2990.2010.01130.x
   PubMed Web of Science ®Google Scholar
• Norberg J, Graff C, Almkvist O, et al. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. Dement Geriatr Cogn Disord. 2011;32(2):135–142. doi:10.1159/000330492
   PubMed Web of Science ®Google Scholar
• Jefferson AL, Beiser AS, Seshadri S, Wolf PA, Au R. APOE and mild cognitive impairment: the Framingham Heart Study. Age Ageing. 2015;44(2):307–311. doi:10.1093/ageing/afu183
   PubMed Web of Science ®Google Scholar
• Jia L, Xu H, Chen S, et al. The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer’s disease. Alzheimers Dement. 2020;16(12):1613–1623. doi:10.1002/alz.12153
   PubMed Web of Science ®Google Scholar
• Katzman R, Zhang MY, Chen PJ, et al. Effects of apolipoprotein E on dementia and aging in the Shanghai survey of dementia. Neurology. 1997;49(3):779–785. doi:10.1212/WNL.49.3.779
   PubMed Web of Science ®Google Scholar
• Zheng L, Duan J, Duan X, et al. Association of apolipoprotein E (ApoE) polymorphism with Alzheimer’s disease in Chinese population. Curr Alzheimer Res. 2016;13(8):912–917. doi:10.2174/1567205013666160401115307
   PubMed Web of Science ®Google Scholar
• Hsieh TJ, Lee WJ, Liao YC, et al. Association between Alzheimer’s disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan. Aging. 2021;13(13):17237–17252. doi:10.18632/aging.203204
   PubMedGoogle Scholar
• Jiang Y, He T, Deng W, Sun P. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis. Clin Interv Aging. 2017;12:1941–1949. doi:10.2147/CIA.S143632
   PubMed Web of Science ®Google Scholar
• Wang XF, Lin X, Li DY, et al. Linking Alzheimer’s disease and type 2 diabetes: novel shared susceptibility genes detected by cFDR approach. J Neurol Sci. 2017;380:262–272. doi:10.1016/j.jns.2017.07.044
   PubMed Web of Science ®Google Scholar
• Joh Y, Choi WS. Mitochondrial complex I inhibition accelerates amyloid toxicity. Dev Reprod. 2017;21(4):417–424. doi:10.12717/DR.2017.21.4.417
   PubMedGoogle Scholar
• Stojakovic A, Chang SY, Nesbitt J, et al. Partial inhibition of mitochondrial complex I reduces tau pathology and improves energy homeostasis and synaptic function in 3xTg-AD mice. J Alzheimers Dis. 2021;79(1):335–353. doi:10.3233/JAD-201015
   PubMed Web of Science ®Google Scholar
• Davidson Y, Gibbons L, Pritchard A, et al. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer’s disease. Dement Geriatr Cogn Disord. 2007;23(1):60–66. doi:10.1159/000097038
   PubMed Web of Science ®Google Scholar
• Liu Z, Dai X, Zhang J, et al. The interactive effects of age and PICALM rs541458 polymorphism on cognitive performance, brain structure, and function in non-demented elderly. Mol Neurobiol. 2018;55(2):1271–1283. doi:10.1007/s12035-016-0358-5
   PubMed Web of Science ®Google Scholar
• Li G, Bekris LM, Leong L, et al. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3. Alzheimers Dement. 2013;9(5):554–561. doi:10.1016/j.jalz.2012.06.009
   PubMed Web of Science ®Google Scholar
• Han X, Jiang Z, Li Y, et al. Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study. BMC Geriatr. 2021;21(1):158. doi:10.1186/s12877-021-02116-x
   PubMed Web of Science ®Google Scholar
• Dong Y, Wang Y, Liu K, et al. Olfactory impairment among rural-dwelling Chinese older adults: prevalence and associations with demographic, lifestyle, and clinical factors. Front Aging Neurosci. 2021;13:621619. doi:10.3389/fnagi.2021.621619
   PubMed Web of Science ®Google Scholar
• Cong L, Ren Y, Hou T, et al. Use of cardiovascular drugs for primary and secondary prevention of cardiovascular disease among rural-dwelling older Chinese adults. Front Pharmacol. 2020;11:608136. doi:10.3389/fphar.2020.608136
   PubMed Web of Science ®Google Scholar
• Zhu JR, Gao RL, Zhao SP, et al. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29.
   PubMedGoogle Scholar
• Rabe-Jabłońska J, Bieńkiewicz W. [Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV – options book]. Psychiatr Pol. 1994;28(2):255–268. Polish.
   PubMedGoogle Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.005
   PubMed Web of Science ®Google Scholar
• Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men. The mayo clinic study of aging. Neurology. 2010;75(10):889–897. doi:10.1212/WNL.0b013e3181f11d85
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360–368. doi:10.1001/archgenpsychiatry.2010.22
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S, Maezawa I, et al. Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer’s disease. EBioMedicine. 2015;2(4):294–305. doi:10.1016/j.ebiom.2015.03.009
   PubMed Web of Science ®Google Scholar
• Bellou E, Baker E, Leonenko G, et al. Age-dependent effect of APOE and polygenic component on Alzheimer’s disease. Neurobiol Aging. 2020;93:69–77. doi:10.1016/j.neurobiolaging.2020.04.024
   PubMed Web of Science ®Google Scholar
• Ding D, Zhao Q, Guo Q, et al. The Shanghai aging study: study design, baseline characteristics, and prevalence of dementia. Neuroepidemiology. 2014;43(2):114–122. doi:10.1159/000366163
   PubMed Web of Science ®Google Scholar
• Ding D, Zhao Q, Guo Q, et al. Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai aging study. Alzheimers Dement. 2015;11(3):300–309.e302. doi:10.1016/j.jalz.2013.11.002
   PubMed Web of Science ®Google Scholar
• Hu P, Qin YH, Jing CX, Lu L, Hu B, Du PF. Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations. Mol Biol Rep. 2011;38(1):489–494. doi:10.1007/s11033-010-0132-0
   PubMed Web of Science ®Google Scholar
• Liang S, Pan M, Geng HH, et al. Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters. Mol Biol Rep. 2009;36(6):1251–1256. doi:10.1007/s11033-008-9305-5
   PubMed Web of Science ®Google Scholar
• Kulminski AM, Shu L, Loika Y, et al. APOE region molecular signatures of Alzheimer’s disease across races/ethnicities. Neurobiol Aging. 2020;87:141.e141–141.e148. doi:10.1016/j.neurobiolaging.2019.11.007
   PubMed Web of Science ®Google Scholar
• Orr AL, Kim C, Jimenez-Morales D, et al. Neuronal apolipoprotein E4 expression results in proteome-wide alterations and compromises bioenergetic capacity by disrupting mitochondrial function. J Alzheimers Dis. 2019;68(3):991–1011. doi:10.3233/JAD-181184
   PubMed Web of Science ®Google Scholar
• Yin J, Reiman EM, Beach TG, et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020;94(23):e2404–e2411. doi:10.1212/WNL.0000000000009582
   PubMed Web of Science ®Google Scholar